GENELUX Corp SEC filings GNLX
GENELUX Corp has 359 filings in SEC EDGAR's recent list, going back to May 5, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 22, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| 424B5 | Prospectus supplement | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Jan 7, 2026 | — |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 424B5 | Prospectus supplement | Mar 25, 2025 | — |
| FWP | Free writing prospectus | Mar 25, 2025 | — |
| 424B5 | Prospectus supplement | May 24, 2024 | — |
| 424B5 | Prospectus supplement | May 23, 2024 | — |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| S-3 | Shelf registration | Feb 2, 2024 | — |
| S-8 | Employee stock plan registration | Nov 15, 2023 | — |
| S-1 | Registration statement | Jun 28, 2023 | — |
| S-8 | Employee stock plan registration | Jan 26, 2023 | — |
| 424B4 | Prospectus | Jan 26, 2023 | — |
| FWP | Free writing prospectus | Jan 13, 2023 | — |
| S-1/A | Amended registration statement | Jan 10, 2023 | — |
| S-1/A | Amended registration statement | Dec 23, 2022 | — |
| FWP | Free writing prospectus | Nov 4, 2022 | — |
| S-1/A | Amended registration statement | Nov 4, 2022 | — |
| S-1/A | Amended registration statement | Oct 13, 2022 | — |
| FWP | Free writing prospectus | Oct 4, 2022 | — |
| S-1/A | Amended registration statement | Sep 19, 2022 | — |
| S-1/A | Amended registration statement | Aug 29, 2022 | — |
| S-1 | Registration statement | Jun 24, 2022 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GNLX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1231457
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.